CYBERKNIFE SYSTEM

Basal Cell Carcinoma of the Lower Left Eyelid

Case History

AGE: 83-year-old
GENDER: Male

Diagnosis: Recurrent infiltrating basal cell carcinoma of the left lower eyelid

Radiotherapy tolerance: Grade II conjunctivitis, Grade II eye watering, Grade III dermatitis

Planning CT Images

Treatment Plan Images

Treatment Planning Highlights

Fractionation

50.4 Gy in 14 fractions

PTV(s) Volume

PTV, 7.2 cc

Dose Distributions

  • Prescription to the 76% isodose line
  • Max. dose 66 Gy

Collimator

Iris Variable Aperture Collimator

Dose Calculation Algorithm

Monte Carlo

New Conformality Index (nCI)

nCi = 1.34

Protocol Used

SABR UK Consortium

Treatment Delivery Information

Tracking Method

Synchrony® Skull Tracking™

Total Delivery Time

21 minutes

Medical Affairs

Accuray Medical Affairs serves as your comprehensive resource hub for clinical evidence, and peer collaboration through our user community.

Services

Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.

Solutions

From robotic to helical radiation therapy delivery, we invent unique, market-changing solutions that are designed to deliver radiation treatments across a full spectrum of patient needs.

Treatment Centers

Radiosurgery

Adaptive Radiotherapy

Systems integration

What's New

Your go-to source for staying informed about our advancements.

Why Accuray

Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.